Bacil Pharma PB Ratio

Bacil Pharma Ltd Price to Book Ratio

The Bacil Pharma Ltd Price to Book Ratio is a key financial metric used by investors to evaluate Bacil Pharma Ltd's valuation, profitability, and overall financial performance. Tracking the Bacil Pharma Ltd Price to Book Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Bacil Pharma Ltd (NSE: , BSE: 524516) is currently trading at ₹48.10, with a market capitalization of ₹726.69M. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Bacil Pharma Ltd Price to Book Ratio is essential for fundamental analysis.

Bacil Pharma Ltd Price to Book Ratio Current Value

The current Bacil Pharma Ltd Price to Book Ratio stands at 0.

The Bacil Pharma Ltd Price to Book Ratio remains stable, indicating consistent financial performance.

Bacil Pharma Ltd Price to Book Ratio Historical Trend

The Bacil Pharma Ltd Price to Book Ratio has shown the following historical trend:

The decline in Bacil Pharma Ltd Price to Book Ratio indicates improving financial efficiency or better earnings growth.

What Bacil Pharma Ltd Price to Book Ratio Indicates for Investors

The Bacil Pharma Ltd Price to Book Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/B ratio shows how the market values company assets relative to book value.

Bacil Pharma Ltd Price to Book Ratio Analysis Summary

The Bacil Pharma Ltd Price to Book Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Bacil Pharma Ltd Price to Book Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Bacil Pharma Ltd Price to Book Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.